TRHC’s MedWise Risk Score™ was introduced in 2017.
The MedWise Risk Score (MRS) is a quick and easy way to assess which patients are at highest risk for ADEs and require most immediate medication management attention. The MRS value is calculated using active medication ingredients of a patient’s entire medication profile, including over-the-counter medications, herbals, and supplements.
In our study of almost one million patients, a risk score of 20 or higher was found to be associated with increasingly higher medical expenditures, including for emergency department visits and hospitalizations. On average, of the cohorts for which we have performed medication risk stratification, about 20% of patients over 65 have a medication risk score equal to or greater than 20, and thus are at high or very high risk for ADEs. For patients 64 and younger, on average, 7 – 10% are at high or very high risk.
We have also shown that focused collaboration with board-certified pharmacists can have a material effect in reducing these medication risk scores.
New! Recent Study Shows that Higher Risk Scores are Associated with Premature Mortality
A study recently published in the Journal of Patient Safety demonstrated that medication risk score is a powerful indicator of increased risk of death among patients taking one or more medications, adding to the growing body of evidence validating TRHC’s MRS as an indicator for negative clinical outcomes.